Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) plans to offer $50 million aggregate principal amount of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE